Found: 11
Select item for more details and to access through your institution.
Human cytomegalovirus UL18 prevents priming of MHC-E– and MHC-II–restricted CD8<sup>+</sup> T cells.
- Published in:
- Science Immunology, 2024, v. 9, n. 100, p. 1, doi. 10.1126/sciimmunol.adp5216
- By:
- Publication type:
- Article
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 7, p. 1, doi. 10.1371/journal.ppat.1009278
- By:
- Publication type:
- Article
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine.
- Published in:
- Nature, 2011, v. 473, n. 7348, p. 523, doi. 10.1038/nature10003
- By:
- Publication type:
- Article
Myeloid cell tropism enables MHC-E–restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.
- Published in:
- Science Immunology, 2022, v. 7, n. 72, p. 1, doi. 10.1126/sciimmunol.abn9301
- By:
- Publication type:
- Article
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacy.
- Published in:
- Science Immunology, 2021, v. 6, n. 57, p. 1, doi. 10.1126/sciimmunol.abg5413
- By:
- Publication type:
- Article
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 501, p. 1, doi. 10.1126/scitranslmed.aaw2607
- By:
- Publication type:
- Article
Enhancing safety of cytomegalovirus-based vaccine vectors by engaging host intrinsic immunity.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 501, p. 1, doi. 10.1126/scitranslmed.aaw2603
- By:
- Publication type:
- Article
Corrigendum: Immune clearance of highly pathogenic SIV infection.
- Published in:
- Nature, 2014, v. 514, n. 7524, p. 654, doi. 10.1038/nature13840
- By:
- Publication type:
- Article
Immune clearance of highly pathogenic SIV infection.
- Published in:
- Nature, 2013, v. 502, n. 7469, p. 100, doi. 10.1038/nature12519
- By:
- Publication type:
- Article
Viral escape mutations do not account for non-protection from SIVmac239 challenge in RhCMV/SIV vaccinated rhesus macaques.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1444621
- By:
- Publication type:
- Article
Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
- Published in:
- PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210252
- By:
- Publication type:
- Article